视界扫描和罕见疾病的药物支出:意大利的三年预测模型 2025-202727年
Andrea Marcellusi1, Daniela Cazzato2, Giulio Guarnotta3
1Department of Pharmaceutical Science (DISFARM), University of Milan, Milan, Italy.
Health economics review
|November 26, 2025
概括
意大利对罕见疾病的孤儿药物 (RDs) 的支出预计将大幅增加. 未来的医疗保健预算必须考虑到创新研发和开发治疗的成本上升,估计在2024年将达到2080亿欧元.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 罕见疾病研究 罕见疾病研究
背景情况:
- 近年来,意大利的孤儿药费用大幅增加.
- 针对罕见疾病的药物 (RDs) 代表了制药市场的不断增长的部分.
研究的目的:
- 预测未来在意大利为罕见疾病 (RDs) 药品的支出.
- 估计孤儿药对意大利医疗保健预算的财务影响.
主要方法:
- 使用Biomedtracker和临床试验数据库开发了一个三年预测模型.
- 每位患者的成本估计使用每个指示的比较器.
- 支出预测包括流行数据,符合条件的人口和吸毒趋势.
主要成果:
- 在2024年,对RD治疗的总支出预计为2080亿欧元,平均每名患者的成本为24,777欧元.
- 预计2025年支出将增加1.9%,2026年增加4.0%,2027年增加7.1%.
- 在2024年,对孤儿指定药物的支出估计为193亿欧元,患者的平均成本为22,984.4欧元.
结论:
- 孤儿药物对意大利的医疗保健预算有着显著且日益增长的财务影响.
- 这项分析提供了为确保获得创新的罕见疾病治疗方法所需资源的定量预测.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Pharmacokinetic Models: Comparison and Selection Criterion
314
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
314
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
470
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
470


